Medication info
Telmira Plus Tablets 40/12.5 mg

Telmira Plus Tablets 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White or almost white, biconvex, round tablet
Packaging
30 tablets (10 tablets/PTP X 3)
Approval status
Active

MFDS item code 201503335 · Approved 2015.05.29 · Insurance code 657805590

Summary

Main use
Treatment of essential hypertension inadequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take this medicine once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution in patients with mild to moderate hepatic impairment. Do not administer this medicine at doses exceeding 40/12.5mg once daily. Do not administer this medicine to patients with severe hepatic impairment (see 2. of Precautions for Use). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dosage adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medicine is used for the treatment of essential hypertension. It is administered additionally to patients whose blood pressure is not adequately controlled with telmisartan alone, improving blood pressure control. This helps to reduce the risk of complications due to hypertension and maintain health.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take this medicine once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution in patients with mild to moderate hepatic impairment. Do not administer this medicine at doses exceeding 40/12.5mg once daily. Do not administer this medicine to patients with severe hepatic impairment (see 2. of Precautions for Use). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dosage adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medicine can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, and should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to the main ingredients or excipients of this medicine, or who are hypersensitive to sulfonamide-class drugs, should not take it. Patients with severely impaired liver or kidney function, those with obstructive biliary disease, and pregnant or breastfeeding women should not take this medicine. Elderly patients, those with hyperkalemia, mildly impaired liver function, and patients with heart valve diseases should exercise caution when taking this medicine. This medicine may lower blood pressure, which could lead to symptoms such as dizziness and fainting; therefore, caution is advised. The hydrochlorothiazide component can cause electrolyte imbalances, and regular blood tests to check potassium and sodium levels are necessary. During the use of this medicine, care should be taken to avoid excessive sun exposure, and if there are any skin abnormalities, a doctor should be consulted immediately. Drug interactions may occur when taken together with other antihypertensive medications, diuretics, lithium, potassium supplements, etc., so patients must inform healthcare providers about all medications they are taking. Dizziness or drowsiness may occur while driving or operating machinery, so caution is necessary. In case of overdose, symptoms such as low blood pressure, electrolyte abnormalities, dehydration may appear; therefore, the dosage must be strictly adhered to, and any unusual symptoms must be reported to healthcare providers immediately. This medicine is not recommended for children under 18 years of age, as its safety and efficacy have not been established. Keep this medicine out of reach of children, and it is advisable to take it immediately after removing it from the package.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 135 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • hepatic disorders
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased serum creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • angioedema
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • myasthenia
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • increased liver enzymes
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • acute renal failure
  • diabetes
  • myasthenia
  • fever
  • nausea
  • abdominal pain
  • gastrointestinal bleeding
  • esophagitis
  • dyspepsia
  • headache
  • tremors
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • increased creatine phosphokinase
  • proteinuria
  • rash
  • itching
  • myalgia
  • dizziness
  • lip and hand tremors
  • sensory hyperesthesia
  • decreased vision
  • hypotension
  • tachycardia
  • bradycardia
  • hypokalemia
  • hypochloremia
  • dehydration
  • muscle cramps
  • nausea
  • somnolence
  • hypokalemia
  • hypochloremia
  • pulmonary edema
  • acute respiratory distress syndrome
  • abdominal pain
  • nausea
  • vomiting
  • constipation
  • pancreatitis
  • angioedema
  • vasculitis
  • acute myopia
  • angle-closure glaucoma
  • choroidal exudation
  • acute respiratory distress syndrome
  • intestinal angioedema

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to prevent air and moisture from entering and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medicine's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

White or almost white, biconvex, round tablet

Package unit

30 tablets (10 tablets/PTP X 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.